Barbara Binzak Blumenfeld, shareholder in the firm's FDA & Biotechnology section, is quoted in the Bloomberg Law article, "FDA’s Booster OK Puts Pfizer on Data Hunt, Muddles Off-Label Use"
We follow industry news and trends so you can stay ahead of the game. Subscribe to receive emails regarding policies and findings that impact you and your business.
Already a subscriber and want to update your preferences? Click here.